Osaic Holdings
NDRA icon

Osaic Holdings’s ENDRA Life Sciences NDRA Stock Holding History

Osaic Holdings’s Portfolio NDRA Stock Details NDRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3
Closed -$10.3K – 7539
2023
Q1 		$10.3K Hold
3
– – ﹤0.01% 5963
2022
Q4 		$18K Hold
3
– – ﹤0.01% 5644
2022
Q3 		$28K Hold
3
– – ﹤0.01% 5347
2022
Q2 		$21K Buy
3
+2
+200% +$17.9K ﹤0.01% 5579
2022
Q1 		$17K Hold
1
– – ﹤0.01% 5814
2021
Q4 		$30K Hold
1
– – ﹤0.01% 5496
2021
Q3 		$76K Hold
1
– – ﹤0.01% 4771
2021
Q2 		$96K Buy
+1
New +$78.7K ﹤0.01% 4509
2021
Q1 		– Hold
0
– – – 6384

Other funds holding NDRA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WAM
Worth Asset Management Dallas, Texas $313M AUM 37.93% 1-Year Est. Return

Osaic Holdings's NDRA Position: Q2 2023 in Review

Osaic Holdings sold out of ENDRA Life Sciences (NDRA) in Q2 2023, closing a stake of 3 shares — an estimated $10.3K sold.

Osaic Holdings first reported a position in NDRA in Q2 2021 and held it in 8 quarters. The position peaked at $96K in Q2 2021. 8 funds tracked by Wall St. Rank hold NDRA as of Q2 2023.

  • Osaic Holdings reported no remaining ENDRA Life Sciences position as of Q2 2023 after selling out during the quarter.
  • Osaic Holdings sold 3 ENDRA Life Sciences shares in Q2 2023, an estimated $10.3K.
  • Osaic Holdings first reported a position in ENDRA Life Sciences in Q2 2021 and held it in 8 quarters.
  • Osaic Holdings's ENDRA Life Sciences position peaked at $96K in Q2 2021.
  • 8 funds tracked by Wall St. Rank held ENDRA Life Sciences as of Q2 2023.

Based on Osaic Holdings's 13F filing for Q2 2023, filed 10 Aug 2023.